PMID: 9444454Jan 28, 1998Paper

Modeling the lifetime costs of treating schizophrenia in Australia

Clinical Therapeutics
C Langley-Hawthorne

Abstract

Schizophrenia is arguably one of the most costly mental illnesses in terms of its impact on the economy, on the health system, and on patients and their families. This paper provides a framework for analyzing schizophrenia; this framework, in a limited data environment, generates estimates of the costs and outcomes of this disease based on location of treatment. This model differs from previous cost-of-illness studies in that it uses a Markov framework to estimate the incidence costs associated with schizophrenia based on a projected amount of a patient's lifetime spent in these treatment locations. The author believes this is the first time such a model has been developed and applied to estimating not only the community costs of schizophrenia but also the cost implications of treatment options and policy choices in Australia. Using a fundamental matrix solution, lifetime costs of illness are calculated and the principal cost drivers in schizophrenia treatment are identified.

References

Sep 1, 1975·The American Journal of Psychiatry·J G Gunderson, L R Mosher
Jan 1, 1991·The American Journal of Psychiatry·G A Keepers, D E Casey
Jan 1, 1991·Schizophrenia Bulletin·G Andrews
Jan 1, 1991·Schizophrenia Bulletin·H Häfner, W an der Heiden
Jan 1, 1991·Chest·T GevaR Van Praagh
Jan 1, 1990·Schizophrenia Bulletin·H Y Meltzer
Aug 1, 1990·Hospital & Community Psychiatry·H Y MeltzerL F Ramirez
Jan 1, 1989·Schizophrenia Bulletin·P Allebeck
Jun 1, 1985·Archives of General Psychiatry·G AndrewsD Silove
Jul 1, 1974·Archives of General Psychiatry·T Van Putten
Mar 1, 1984·The Australian and New Zealand Journal of Psychiatry
Jan 1, 1983·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J R Beck, S G Pauker
Jan 1, 1982·Schizophrenia Bulletin·D M EngelhardtP Cohen
Jan 1, 1981·Schizophrenia Bulletin·E F Torrey
Jan 1, 1995·Schizophrenia Bulletin·D ShoreJ A Lieberman
Jan 1, 1995·Schizophrenia Bulletin·S M Evers, A J Ament
Jan 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·K SmithG Lewis
Jan 1, 1994·Schizophrenia Bulletin·H R Winefield, E J Harvey
Nov 1, 1993·The American Journal of Psychiatry·H Y MeltzerB Snitz
Oct 1, 1993·Medical Decision Making : an International Journal of the Society for Medical Decision Making·F A Sonnenberg, J R Beck
Jan 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·L M Davies, M F Drummond
Oct 1, 1996·Archives of General Psychiatry·B DickeyF Altaffer

❮ Previous
Next ❯

Citations

Mar 11, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Karina HansenMondher Toumi
Sep 18, 2004·Schizophrenia Research·Penny E MohrPeter J Neumann
Jan 22, 2003·The Australian and New Zealand Journal of Psychiatry·Amanda L NeilVaughan J Carr
Sep 11, 2007·The Australian and New Zealand Journal of Psychiatry·Paul B FitzgeraldJayashri Kulkarni
Jun 1, 2006·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Ruth Williams, Darrel Doessel
Feb 20, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Simon FreyTom Stargardt
Feb 1, 2005·Expert Review of Pharmacoeconomics & Outcomes Research·Reinhold Kilian, Thomas Becker
Oct 8, 2013·The Australian and New Zealand Journal of Psychiatry·Amanda L NeilVera A Morgan
Jul 9, 2009·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Paul FitzgeraldJayashari Kulkarni
Sep 1, 2006·PharmacoEconomics·Ebere AkobunduC Daniel Mullins
Aug 26, 2016·PharmacoEconomics·Huajie Jin, Iris Mosweu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Schizophrenia Bulletin
S M Evers, A J Ament
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
K HansenC Lançon
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
M Seshamani
© 2021 Meta ULC. All rights reserved